Validation of plasma proteomic biomarkers relating to brain amyloid burden in the EMIF-Alzheimer's disease multimodal biomarker discovery cohort

  1. Westwood, S.
  2. Baird, A.L.
  3. Anand, S.N.
  4. Nevado-Holgado, A.J.
  5. Kormilitzin, A.
  6. Shi, L.
  7. Hye, A.
  8. Ashton, N.J.
  9. Morgan, A.R.
  10. Bos, I.
  11. Vos, S.J.B.
  12. Baker, S.
  13. Buckley, N.J.
  14. Ten Kate, M.
  15. Scheltens, P.
  16. Teunissen, C.E.
  17. Vandenberghe, R.
  18. Gabel, S.
  19. Meersmans, K.
  20. Engelborghs, S.
  21. De Roeck, E.E.
  22. Sleegers, K.
  23. Frisoni, G.B.
  24. Blin, O.
  25. Richardson, J.C.
  26. Bordet, R.
  27. Molinuevo, J.L.
  28. Rami, L.
  29. Wallin, A.
  30. Kettunen, P.
  31. Tsolaki, M.
  32. Verhey, F.
  33. Lléo, A.
  34. Sala, I.
  35. Popp, J.
  36. Peyratout, G.
  37. Martinez-Lage, P.
  38. Tainta, M.
  39. Johannsen, P.
  40. Freund-Levi, Y.
  41. Frölich, L.
  42. Dobricic, V.
  43. Legido-Quigley, C.
  44. Bertram, L.
  45. Barkhof, F.
  46. Zetterberg, H.
  47. Morgan, B.P.
  48. Streffer, J.
  49. Visser, P.J.
  50. Lovestone, S.
  51. Show all authors +
Journal:
Journal of Alzheimer's Disease

ISSN: 1875-8908,  1387-2877

Year of publication: 2020

Volume: 74

Issue: 1

Pages: 213-225

Type: Article

DOI: 10.3233/JAD-190434 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus